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STUDY QUESTION: What are the perceptions of ESHRE members about the dissemination, implementation and impact of the ﬁrst four
ESHRE evidence-based guidelines to be published?
SUMMARY ANSWER: Around 30% of ESHRE members know and use the ESHRE evidence-based guidelines in their routine practice and
this is perceived to result in better treatment, better screening/evaluation/diagnosis and better psychosocial and patient-centred care, with on
average three in each four members who make changes perceiving that their patients beneﬁt from it.
WHAT IS KNOWN ALREADY: ESHRE has been developing and disseminating evidence-based guidelines, aiming to improve the quality
of fertility care across Europe. However, evidence has shown that guidelines dissemination is not enough to change practice at clinics, with
implementation strategies that address local barriers to implementation being recommended.
STUDY DESIGN, SIZE, DURATION: A cross-sectional study based on an online survey was sent by email to all ESHRE members
(n=7664) and advertised on ESHRE social media (20 February–3 April 2018). The survey was carried out to evaluate their perceptions about
the dissemination, implementation and impact of the Management of Endometriosis (ENDO), Routine Psychosocial Care (RPC), Premature
Ovarian Insufficiency (POI) and Recurrent Pregnancy Loss (RPL) ESHRE guidelines.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The survey was advertised via the ESHRE website, social media and email to all
ESHRE members. It assessed the dissemination (knowledge the guidelines were published, downloaded), implementation (using guidelines in
daily practice, changed practice) and impact (perceived patient beneﬁt, referred patients to the guidelines) of the guidelines, as well as their
perceived implementability. Open questions assessed perceived changes in practice, barriers to and desired support for implementation.
MAIN RESULTS AND THE ROLE OF CHANCE: The ﬁnal sample consisted of 658 participants (not possible to calculate response rate),
with the majority being embryologists, biologists or geneticists (n=268, 40.7%), followed by clinicians (n=260, 39.5%), scientists (n=48,
7.3%), nurses or midwives (n=30, 4.6%), psychologists, counsellors or social workers (n=28, 4.3%) and others (e.g. medical student, lab
manager, marketing, ethicist; n=24, 3.6%). The majority knew that ESHRE published the guidelines (82.1% ENDO, 54.6% RPC, 56.6% POI,
59.4% RPL). From these, the majority downloaded it (65.9% ENDO, 52.4% RPC, 54.2% POI, 56.8% RPL), around one-third used it in their
routine practice (41.7% ENDO, 29.5% RPC, 33.7% POI) and around one quarter made changes to their practice (30.7% ENDO, 18.9% RPC,
21.5% POI). Overall, <20% of members think that patients beneﬁted from the guideline (19.4% ENDO, 16.3% RPC, 16.1% POI) and very few
referred them to it (ENDO8.9%, 12.8% RPC, 16.1% POI). However, on average every three in every four people whomade changes to practice
perceived that their patients beneﬁted from it (ENDO 62%, RPC 80%, POI 75%). The main reported changes in practice were better treatment,
better screening/evaluation/diagnosis and better psychosocial and patient-centred care. Main perceived barriers to implementation were lack
of translation to other languages, guidelines being long and difficult to understand and lack of supporting evidence. Financial constraints and
lack of staff expertise were also reported. Participants desired clear support for implementation in the form of step-by-step instructions, more
training and support materials for staff and patients and translation to other languages. Results for the clinicians only showed that, despite less
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knowledge about the RPC guideline, they were more likely to download all the guidelines, to follow them, make changes in their daily practice
and refer them to their patients.
LIMITATIONS, REASONS FOR CAUTION: Respondents were ESHRE members and these are not representative of all European
reproductive health professionals. The response rate could not be calculated as ESHRE social media reaches more than just the members.
The guidelines are mainly written for clinicians and in this sample the clinicians were under-represented. In addition, missing values increased
as participants progressed through each guideline’s questions, with the open-ended questions being answered by only 74–97 participants. The
survey assessed perceptions instead of actual practice. Overall, the results may convey a too optimistic picture of the impact of the guidelines.
WIDER IMPLICATIONS OF THE FINDINGS: ESHRE’s policy of investing in implementation and dissemination is important but
insufficient to ensure the guidelines are implemented at clinics across Europe. ESHRE can address perceived barriers that are directly related to
the guidelines, in particular lack of translation, as well as provide further support for implementation. This support should be clear and concise,
focusing on how to implement the guidelines rather than on what to do.
STUDY FUNDING/COMPETING INTEREST(S): None.
Key words: endometriosis / premature ovarian failure / recurrent miscarriage / psychology / counselling / assisted reproduction /
infertility / ESHRE
WHAT DOES THIS MEAN FOR PATIENTS?
Evidence-based guidelines are a set of recommendations about how staff in fertility clinics should provide care to their patients, which are based
on the most high quality and up-to-date scientiﬁc research. ESHRE has been developing evidence-based guidelines in an effort to improve the
quality of fertility care across Europe. However, publishing and advertising guidelines is not enough to ensure that fertility staff will actually follow
the recommendations when attending to their patients.
We did an online survey to ask ESHRE members if they know about and follow the ESHRE guidelines, and if they think their patients beneﬁt
from this. We also asked them about how following the guidelines changed their practice, what makes it difficult for them to use the guidelines
and what support they think could be beneﬁcial.
Results from the survey show that the majority of ESHRE members know the guidelines are available, but only ∼30% follow them. Those
who follow the guidelines think that they are providing better treatment, better diagnosis and better psychosocial and patient-centred care to
their patients. On average, three in every four members who made changes to their daily practice perceived that their patients beneﬁted from
it. However, the guidelines are long and difficult to understand and are usually not translated to other languages (beyond English). If ESHRE is
able to address these issues, in particular translation of the guidelines, fertility staff may feel more empowered to follow the guidelines, and this
can mean better care for their patients.
Introduction
Between 2013 and 2017 ESHRE published four systematically devel-
oped and evidence-based clinical practice guidelines [Management of
Endometriosis (ENDO; Dunselman et al., 2014), Routine Psychoso-
cial Care (RPC; Gameiro et al., 2015), Premature Ovarian Insuffi-
ciency (POI;Webber et al., 2016) and Recurrent Pregnancy Loss (RPL)
(Atik et al., 2018)] with the aim of supporting care providers and
patients making every-day decisions about appropriate and effective
health care (Vermeulen et al., 2017). Since then ESHRE has endorsed
one more evidence-based guideline and has three under develop-
ment. The goal of the present study is to evaluate the dissemina-
tion, implementation and impact of the ﬁrst four published ESHRE
guidelines.
ESHRE’s motivation to develop clinical practice guidelines is ‘to
improve the quality of health care delivery within the European ﬁeld of
human reproduction and embryology’ (Vermeulen et al., 2017, p. 5).
With this aim in view, the development of all ESHRE guidelines is
based on a 12-step systematic process intended to maximize their
implementability at clinics (Kashyap et al., 2011). The initial steps of
this process include an exhaustive review and comprehensive synthesis
of the best available relevant evidence and its quality assessment,
in order to ensure that the recommendations developed are valid
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(reﬂect the strength of evidence available) and measurable (identify
outcomes to measure the effect of implementation). The subsequent
steps in the process aim at the adequate translation of the evidence
into a set of best practice recommendations designed to ensure,
among other characteristics, their executability (say exactly what to
do), decidability (say precisely under what conditions) and ﬂexibility
(allow for interpretation and alternatives in execution). This last two
steps of a stakeholder consultation focusing on ensuring that the clinical
content of the recommendations and their applicability are adequate,
followed by the ﬁnal approval of the resulting document by the ESHRE
Executive Committee (Vermeulen et al., 2017).
ESHRE has also been making a very signiﬁcant investment in the
dissemination of the guidelines, which includes making them available
online in various professional and patient-friendly formats (e.g. via the
ESHRE website, ESHRE journals, a pocketsize version), advertising
and distributing them widely (e.g. social media, ESHRE meetings, via
national societies), developing apps and online training courses and
working collaboratively with multiple national societies to promote
their endorsement and translation into different languages. As an exam-
ple, the RPC guideline (https://www.eshre.eu/Guidelines-and-Legal/
Guidelines/Psychosocial-care-guideline.aspx) has been published in
ﬁve formats (full document, summary document, patient versions,
pocketsize version and a paper inHuman Reproduction) and is currently
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translated into Dutch, Greek and Spanish. ESHRE has also made avail-
able additional educational materials and produced podcasts focusing
on different aspects of these guidelines and is currently developing
an e-campus course with the aim of supporting fertility staff in their
day-to-day implementation.
The implementation of trustworthy guidelines should reduce inap-
propriate practice variation (Institute of Medicine, 2011), but so far
ESHRE has put little emphasis on ensuring that its guidelines are being
implemented across Europe. It is well established that publishing and
disseminating guidelines is not enough for health care providers to
change their daily practice towards guidelines adherence. However,
it is also clear that no single implementation strategy will efficiently
ensure implementation at a European level. Indeed, implementation
is known to vary nationally and locally depending on existing barri-
ers related to the guidelines themselves (e.g. is it translated to the
country’s language), the health care providers (e.g. staff attitudes and
expertise), the social and clinical setting (e.g. clinic’s characteristics)
and the system (e.g. legal, ﬁnancial constrains; Shiffman et al., 2005).
The consequence is that efficient implementation strategies need to
target the speciﬁc barriers affecting local practice (Baker et al., 2010).
It is based on this argument that ESHRE has taken responsibility
for the implementability of its guidelines (i.e. ensuring that they are
implementable), but not directly for their implementation into local
practice.
The current study reports on an online survey designed to provide
preliminary evidence of the implementability and implementation of
the ﬁrst four published ESHRE guidelines (ENDO, RPC, POI and
RPL). More speciﬁcally, the survey assesses dissemination (knowledge
that the guidelines exist and access to them), implementation
(using guidelines and making changes to practice according to
guideline recommendations) and impact (referral of patients to
the patient-friendly version of guidelines, perceived patient ben-
eﬁt). It further investigates the perceived implementability of the
guidelines (across multiple dimensions), barriers to implementation
and perceived beneﬁcial support for their implementation. The
results will indicate the extent to which the ESHRE guidelines are
being used across Europe (and beyond) to promote evidence-based
clinical decision-making and improve fertility healthcare quality and
safety.
Materials and Methods
Study design
A cross-sectional study was conducted using an online survey, which
focused on the ﬁrst four evidence-based guidelines published by ESHRE
(ENDO, RPC, POI and RPL).
The survey
The survey was organized in two sections: the ﬁrst focused on the
participants’ background and the second on the guidelines. For each
guideline, participants were presented with questions focusing on the
following: dissemination, implementation and impact of the guidelines;
their implementability; changes made in practice as a result of imple-
menting the guidelines; and perceived barriers and desired support
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
for implementing the guidelines. These questions were presented
sequentially in the following order: ENDO, RPC, POI and RPL. Because
the RPL guidelines had just been published, a few questions were
omitted or adapted, and this is described below, where we present
the materials in more detail.
Background variables
Participants were asked about their age (in years), gender (male;
female; other), country of work (collapsed into continents) and pro-
fessional background (clinician; embryologist, biologist or geneticist;
scientist; nurse or midwife; psychologist, counsellor or social worker;
and other).
Dissemination, implementation and impact of the guidelines
Participants were asked the following:
• two dissemination questions i.e. if they knew that the guideline was
published (no; yes) and if they had downloaded it (no; yes)
• two implementation questions i.e. if they were using these guidelines
in their routine practice (no; yes) and if they or the clinic had
made changes in their routine practice as a result of applying them
(no; yes)
• two impact questions i.e. to what degree they thought patients had
beneﬁted from the changes implemented (1, not at all; 2, a little bit;
3, somewhat; 4, quite a bit; 5, a tremendous amount, also recoded
into no [not at all]; yes [from a little bit to a tremendous amount])
and if they had referred their patients to the patient version of the
guidelines (no; yes).
The implementation and impact questions were omitted for the
RPL guideline and only one implementation question was asked, if
participants intended to make changes at their clinic based on the
guideline (no; yes).
Implementability of the guidelines
Patients were asked to rate the ENDO, RPC and POI guidelines accord-
ing to the six dimensions of the Guideline Implementability Appraisal
tool (GLIA; Kashyap et al., 2011), namely executability, decidability,
validity, ﬂexibility, effect on process of care and measurability, on a 5-
point Likert scale (from 1, very poor to 5, excellent). Patients were also
asked to provide an overall rating of the four guidelines using the same
response scale.
Changes in practice, barriers to implementation and desired
support for implementation
Participants were presented with a series of open-ended questions,
where they were asked to provide up to three important examples of
how applying the guidelines changed their practice, perceived barriers
for applying the guidelines (for each of the following headings: the
guidelines themselves, the clinical setting, the staff and patients) and
types of desired support to implement the guidelines (for each of the
headings listed above). None of these questions were presented for
the RPL guideline. Finally, participants were asked about their intentions
(yes; maybe; no; do not know) to use different types of implementa-
tion support provided by ESHRE, namely e-learning course, campus
course, guidelines App, printed pocket guidelines and a step-by-step
guide.
D
ow
nloaded from
 https://academ
ic.oup.com
/hropen/advance-article-abstract/doi/10.1093/hropen/hoz011/5511757 by C
ardiff U
niversity user on 07 June 2019
4 Gameiro et al.
Procedure
The survey was posted online from 20 February to 3 April 2018.
Multiple recruitment strategies were used. The study was advertised
via two emails to the ESHREmembership (n=6764) and via the ESHRE
social media. Participants were offered the opportunity to win a free
registration for the ESHRE Annual Meeting in Barcelona or an ESHRE
Campus Course.
Statistical analysis
Descriptive statistics were performed to analyse participants’ back-
ground, the dissemination, implementation and impact of the guide-
lines, their perceived implementability and intentions to use support
provided by ESHRE.
To investigate the factors associated with the use of the guidelines
(dissemination, implementation and impact) multiple logistic regres-
sions were conducted. The following factors were considered: age,
gender (0, male; 1, female or other), professional background (0,
non-clinician; 1, clinician), continent (0, non-European; 1, European)
and overall quality rating of the guideline. For each guideline these
factors were regressed on the two indicators of dissemination, imple-
mentation and impact (total of six regressions per guideline). For the
RPL guideline only the two indicators of dissemination and the future
orientated implementation question were considered (total of three
regressions).
To investigate perceived changes in practice, barriers to and desired
support for implementation of the ENDO, RPC and POI guidelines,
content analysis on the participants’ open-ended responses was con-
ducted. Each participant could contribute up to 11 replies to the group
data, 3 to changes made at clinic, 4 to perceived barriers and 4 to
desired support. We ﬁrst checked if replies had text that could be
coded (the percentage of non-codable answers is presented in results).
Inductive coding was then applied for each question, meaning that
participants’ answers were grouped into meaningful categories, on
the assumption that answers assigned to the same category shared
the same meaning (Cavanagh, 1997). An answer could contain text
referring to different barriers or support and therefore these could be
assigned to more than one category (maximum of two was observed).
This process was carried out independently by S.G. and M.S.L. who
then came together to review their coding. Disagreement about the
coding of each answer or the labels created for the emergent cat-
egories was resolved by discussion until consensus was achieved.
Although the answers for perceived barriers and desired support were
given under speciﬁc headings, they were sometimes placed under a
different one. For instance, the following reply was presented as a
patient barrier: ‘Lack of patient knowledge due to language barrier
(not all patients can understand English)’ but was then placed under
guidelines barriers, as it is not the patient that should adapt to the
guidelines but the guidelines to the patient population. In the third
step, N.V. was asked to review the coding and suggestions for changes
were discussed by the three authors until consensus was achieved.
Finally, descriptive statistics were used to provide the frequency of the
emergent categories for each guideline.
Quantitative data analyses were performedwith IBM© SPSS© Statis-
tics Version 25 (IBM-SPSS, Chicago, IL, USA). No software was used
to perform qualitative analyses.
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Results
Participants
A total of 723 people accessed the survey. Of these, 65 participants
were excluded because they only ﬁlled the background questions. The
ﬁnal sample consisted of 658 participants.
Participants were on average 42.91 years old (SD=11.11, range 20–
78). The majority were women (n=396, 60.2%), with the remaining
being men (n=253, 38.4%) and one participant stating other (0.2%).
The participants were from 95 different countries, and the majority
were based in Europe (n=429, 65.2%), followed by Asia (n=140,
21.3%), South America (n=31, 4.1%), Africa (n=30, 4.6%), North
America (n=18, 2.7%) and Oceania (n=10, 1.5%). The participants
had different professional backgrounds, with the majority being embry-
ologists, biologists or geneticists (n=268, 40.7%), followed by clinicians
(n=260, 39.5%), scientists (n=48, 7.3%), nurses or midwives (n=30,
4.6%), psychologists, counsellors or social workers (n=28, 4.3%) and
others (e.g. medical student, lab manager, marketing, ethicist; n=24,
3.6%). We contrasted these descriptive statistics with the total ESHRE
membership (data not reported). Overall, the sample seems represen-
tative of ESHRE’s membership; however, embryologists, biologists or
geneticists seem to be overrepresented (40.7% versus 30.8% in ESHRE
membership).
Dissemination, implementation and impact
of the guidelines
Participants had to answer multiple questions for each guideline and
address each of the four guidelines in a sequential order (ENDO,
RPC, POI and RPL). The result was that the survey was quite time-
consuming and participants tended to stop answering it at the end of
each guideline, with missing answers increasing sequentially (ENDO: 0,
0%; RPC: 307, 42.5%; POI: 361, 49.9%; and RPL: 388, 53.7%).
Table I presents the results regarding the dissemination, imple-
mentation and impact of the four published ESHRE guidelines
(see Supplementary Table SX for results for clinicians only). The
majority of the participants (≥54.6%) knew that ESHRE had
published the guidelines. From these, the majority (≥52.4%) had
downloaded the four guidelines, around one-third used the ﬁrst
three in their daily practice and around one-fourth reported that
they made or intend to make changes to their practice. For the
ENDO, RPC and POI guidelines, only a minority perceived that
their patients beneﬁted from the guidelines and referred them to the
guidelines.
Factors associated with use of the guidelines
Figure 1 presents a schematic representation of the signiﬁcant associa-
tions found between the factors that were considered to be associated
with use of the guidelines and the dissemination, implementation and
impact indicators.
Logistic regressions investigating the factors associated with
knowing the ENDO guideline (χ 2 = 11.777, df =5, P=0.038),
downloading it (χ 2 = 10.594, df =5, P=0.060), perceiving patient
beneﬁt (χ 2 = 11.139, df =5, P=0.050) and referring them to the
guideline (χ 2 = 7.706, df =5, P=0.173) did not indicate any statistically
signiﬁcant association. The logistic regression showed a signiﬁcant
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Table I Dissemination, implementation and impact of the four published ESHRE guidelines.
ENDO RPC POI RPL
......................................................................................................................................................
Know was
published
q/na 540/658 227/416 205/362 199/335
% [95% CI] 82.07 [78.95–84.81] 54.57 [49.76–59.29] 56.63 [51.48–61.64] 59.40 [54.07–64.53]
Downloaded q/nb 356/540 119/227 111/205 113/199
% [95% CI] 65.93 [61.83–69.80] 52.42 [45.94–58.83] 54.15 [47.31–60.83] 56.78 [49.84–63.47]
Use in daily
practice
q/nb 225/540 67/227 69/205 –
% [95% CI] 41.67 [37.58–45.87] 29.52 [23.96–35.75] 33.66 [27.54–40.38] –
Changes in
practice
q/nb 166/540 43/227 44/205 63/199
% [95% CI] 30.74 [27.00–34.76] 18.94 [14.38–24.54] 21.46 [16.40–27.58] 31.66 [25.60–38.42]
Perceived patient
beneﬁt
q/nb 105/540 37/227 33/205 –
% [95% CI] 19.44 [16.33–22.99] 16.30 [12.06–21.66] 16.10 [11.70–21.74] –
M 4.12 4.30 4.39 –
SD 0.91 0.74 0.86 –
Referred to
patients
q/nb 48/540 29/227 33/205 –
% [95% CI] 8.89 [6.77–11.59] 12.78 [9.04–17.75] 16.10 [11.70–21.74] –
N=658 participants; q, number of participants replying yes to question.
an, number of valid answers (i.e. not missing); ENDO, 658; RPC, 416; POI, 362; RPL, 335.
bn, number of participants who reported knowing the guidelines were published; ENDO, 540; RPC, 227; POI, 205; RPL, 199.
ENDO, Endometriosis; RPC, Routine Psychosocial Care; POI, Premature Ovarian Insufficiency; RPL, Recurrent Pregnancy Loss.
Figure 1 Schematic representation of the statistically signiﬁcant associations (P< 0.05) found between the predictors of the
guidelines’ use and the dissemination, implementation and impact indicators.OR, odd ratios. Guidelines: ENDO, Endometriosis; RPC,
Routine Psychosocial Care; POI, Premature Ovarian Insufficient. See text for full results reporting.
association with using the ENDO guideline in routine practice
(χ 2 = 86.718, df =5, P< 0.001). Clinicians (OR=14.69, 95% CI
[7.22–29.91], P< 0.001) and those attributing a higher quality rating
to the ENDO guideline (OR=1.72, 95% CI [1.12–2.60], P=0.011)
were more likely to use it in their routine practice. The logistic
regression showed a signiﬁcant association with having made changes in
their practice (χ 2 = 15.315, df =5, P=0.009). European participants
were less likely than others to have made changes in their practice
(OR=0.35, 95% CI [0.16–0.79], P=0.011).
Logistic regressions investigating the factors associated with know-
ing the RPC guideline (χ 2 = 9.375, df =5, P=0.095), downloading
it (χ 2 = 6.320, df =5, P=0.276), having made changes in practice
(χ 2 = 10.298, df =5, P=0.067) and perceiving patient beneﬁt (could
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
not be computed as all respondents indicated that they perceived
beneﬁt) did not indicate any statistically signiﬁcant association. The
logistic regression showed a signiﬁcant association with using the RPC
guideline in routine practice (χ 2 = 15.170, df =5, P=0.010). Clinicians
(OR=3.68, 95% CI [1.37–9.86], P=0.010) and those attributing a
higher quality rating to the RPC guideline (OR=2.58, 95% CI [1.17–
5.67], P=0.018) were more likely to use it in their routine practice.
The logistic regression showed a signiﬁcant association with referring
patients to the RPC guideline (χ 2 = 11.719, df =5, P=0.039). Older
participants were less likely to refer their patients to the RPC guideline
(OR=0.92, 95% CI [0.87–0.98], P=0.007).
Logistic regressions investigating the factors associated with know-
ing the POI guideline (χ 2 = 7.441, df =5, P=0.190), downloading
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Figure 2 Quality ratings of the guidelines for the Guideline Implementability Appraisal tool implementability dimensions and
overall.RPL, Recurrent Pregnancy Loss.
it (χ 2 = 8.954, df =5, P=0.111), having made changes in practice
(χ 2 = 5.120, df =5, P=0.401), perceiving patient beneﬁt (could not be
computed as all respondents indicated that they perceived beneﬁt) and
referring them to the guideline (χ 2 = 9.300, df =5, p=0.098) did not
indicate any statistically signiﬁcant association. The logistic regression
showed a signiﬁcant association with using the POI guideline in routine
practice (χ 2 = 33.495, df =5, P< 0.001). Clinicians were more likely
to use it in their routine practice (OR=11.57, 95% CI [3.90–34.32],
P< 0.001).
Finally, logistic regressions investigating the factors associated with
knowing the RPL guideline (χ 2 = 3.090, df =5, P=0.686), download-
ing it (χ 2 = 2.666, df =5, P=0.751) and intending to make changes
in routine practice (χ 2 = 8.159, df =5, P=0.148) did not indicate any
statistically signiﬁcant association.
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Implementability of the guidelines
Figure 2 presents the quality ratings of the guidelines for the GLIA di-
mensions and overall. The average perceived quality of the four guide-
lines was higher than four (good quality; range 4.11–4.26) and ratings
for the different GLIA implementability dimensions of the three guide-
lines tended to be slightly lower or higher than 4 (range 3.54–4.14).
Perceived changes in practice due to
implementing the guidelines
Table II presents the perceived changes in practice due to implementing
the guidelines reported by 97 participants (total of 351 statements
coded, reported in Supplementary Tables SI [ENDO], SIV [RPC]
Table II Reported perceived changes in practice due to implementing the guidelines.
ENDO (n=233),
n (%)
RPC (n=68),
n (%)
POI (n=50),
n (%)
......................................................................................................................................................
Increased awareness/knowledge 6 (2.58) 12 (17.65) 6 (12.00)
Better screening/evaluation/diagnosis 21 (9.01) 8 (11.76) 11 (22.00)
Better general treatment 71 (30.47) 16 (32.00)
Better medical treatment of pain 20 (8.58)
Better surgical treatment 54 (23.18)
Better psychosocial support/counselling 6 (2.58) 16 (23.53) 4 (8.00)
Better patient-centred care 12 (5.15) 7 (10.29) 4 (8.00)
Better education/information provision 19 (8.15) 2 (2.94) 5 (10.00)
Better communication 4 (5.88)
Endometriosis advocacy 2 (0.86)
More interdisciplinary/team work 6 (8.82)
Clinical auditing 1 (0.43) 1 (1.47)
Reduced costs 2 (0.86)
New infrastructures 1 (1.47)
Non-codable 19 (8.15) 11 (16.18) 4 (8.00)
See Supplementary Tables SI/SIV/SVII for the full list of the participants’ answers and the respective category.
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and SVII [POI]). Perceived changes were mostly related to what was
reported as an improvement in the provision of care, either bet-
ter treatment (e.g. ENDO, ‘guiding decision in patient’s treatment
selection’, ‘deciding the most appropriate progestational therapy’;
‘improved safety/effectiveness of treatment’; POI, ‘offering hormone
therapy’, ‘medicine dosage’, ‘proper treatment’), better psychosocial
support/counselling (e.g. ENDO, ‘better counselling of endometriosis
patients with infertility issues’; RPC, ‘offer more psychological support
to patients having fertility treatment’, ‘how to handle those who do not
get positive results’; POI, ‘began counselling of relatives on possible
implications for them’) or overall better patient-centred care (e.g.
ENDO, ‘shorter time for decision-making’; RPC, ‘refer patients at risk
of emotional problems to specialised psychosocial care’, ‘cater to their
psychosocial needs’; POI, ‘follow up of women with POI’). For the
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ENDO guideline perceived changes also reﬂected better screening/
evaluation/diagnosis (e.g. ‘transvaginal sonography in diagnosis of rec-
tal endometriosis’, ‘more consistency among clinicians in grading’) and
better decisions about surgical treatment (e.g. ‘avoiding unnecessary
surgery’, ‘feeling more conﬁdent about my decision to or not to
operate an endometrioma’, ‘it helped me to take a decision about
to make a laparoscopic intervention’) and treatment of pain (e.g.
‘it improved the trust the patient has in our practice by improving
pain management’, ‘pain management’). For the RPC and POI guide-
lines, reported changes also related to an increase in awareness and
knowledge (e.g. RPC, ‘more aware of the effect of the disease on
the couple’, ‘be more aware of the patients’ needs and preferences’,
‘it makes me conscious of the importance of the information’; POI,
‘I was looking for literature and textbook for POI but this guideline
Table III Reported barriers to implementing the guidelines.
ENDO (n=223),
n (%)
RPC (n=82),
n (%)
POI (n=63),
n (%)
......................................................................................................................................................
Guidelines
Unclear/difficult to understand 7 (3.14) 4 (4.88) 4 (6.35)
Too long 18 (8.07) 3 (3.66) 3 (4.76)
Lack of evidence 10 (4.48) 5 (6.10) 3 (4.76)
Language/translation 10 (4.48) 10 (12.20) 8 (12.70)
Topic not relevant/inappropriate/not priority 5 (2.24) 3 (3.66) 1 (1.59)
Lack of speciﬁc information 6 (2.69)
Lack of patient-friendly version/materials 5 (2.24) 1 (1.59)
No dissemination/awareness 1 (0.45) 3 (4.76)
Lack of power 5 (2.24)
Clinical setting and system
Costs/ﬁnancial constrains 16 (7.17) 6 (7.32) 4 (6.35)
Lack of infrastructure/equipment 9 (4.04) 1 (1.22)
Lack of trained/specialised staff 4 (1.79) 1 (1.22)
Culture/norms 3 (1.35) 5 (6.10)
No champion/responsible person 1 (1.22)
Not relevant to clinic patient population 1 (1.22)
Staff
Lack of knowledge/expertise 19 (8.52) 5 (6.10) 4 (6.35)
Lack of time 8 (3.59) 7 (8.54) 2 (3.17)
Lack of power 1 (1.22)
Lack of interest/motivation 2 (0.90) 3 (3.66)
Not personally applicable/relevant 2 (3.17)
Culture/norms 3 (1.35)
Patient
Culture/norms 10 (4.48) 8 (9.76) 1 (1.59)
Costs 5 (2.24) 3 (3.66) 2 (3.17)
No interest/resistance 3 (1.35) 5 (6.10)
Lack of awareness/knowledge 9 (4.04)
No barriers 36 (16.14) 18 (28.57)
Non-codable 29 (13.00) 10 (12.20) 7 (11.11)
See Supplementary Tables SII/SV/SVIII for the full list of the participants’ answers and the respective category.
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is faster and easier to reach from just ESHRE website so time’, ‘well
deﬁned POI’). Finally, for the POI guideline, perceived changes also
concerned screening/evaluation/diagnosis (e.g. ‘right prescriptions to
ﬁnd out a potential cause’, ‘clear and faster diagnosis’, ‘ruling out all
possible causes of POI’).
Perceived barriers to implementation of
guidelines
Table III presents the perceived barriers to implementation of the
guidelines reported by 94 participants (total of 368 statements coded,
reported in Supplementary Tables SII [ENDO], SV [RPC] and SVIII
[POI]). The most prevalent barriers common to the three guidelines
were related to the guidelines themselves, more speciﬁcally, the lack
of translation to languages beyond English (e.g. ENDO, ‘if it is only in
English this would be a problem for some patients’; RPC, ‘only a small
amount of my clients are ﬂuent in English enough to appreciate the
.
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guidelines’; POI, ‘the language barrier is a bit difficult’), the perception
that guidelines are too long and difficult to understand (ENDO, ‘to
long to read and to apply in clinical practice’, ‘unclear recommenda-
tions’; RPC, ‘too large, needs short version of recommendation’, ‘not
attractive to read: difficult and unclear layout at ﬁrst sight’; POI, ‘very
long’, ‘difficult to understand’) and lack supporting evidence (ENDO,
‘content validation’; RPC, ‘not enough evidence to make strong direct
and practical recommendations to clinical staff’; POI, ‘limited evidence
on topic’). Other common barriers were ﬁnancial constrains (ENDO,
‘limited funding’; RPC, ‘cost effectiveness’; POI, ‘costs’) and lack of
staff expertise (e.g. ENDO, ‘sometimes I feel myself in lack of clinical
expertise which’ may be my limitation’; RPC, ‘experience’; POI, ‘lack
of knowledge/expertise’) and time (e.g. ENDO, ‘it is more or less
applicable in our clinic but lacking enough time to come back to the
guidelines’; RPC, ‘no real time to do the promotion more than what
we did’, POI, ‘time’). Patients’ cultural habits and norms, together
with a lack of interest and resistance, were relevant barriers for the
Table IV Reported desired support for implementing the guidelines.
ENDO (n=161),
n (%)
RPC (n=61),
n (%)
POI (n=46),
n (%)
......................................................................................................................................................
Guidelines
Clearer and concise information 19 (11.80) 8 (13.11) 4 (8.70)
Better dissemination of the guidelines 7 (4.35) 2 (3.28) 2 (4.35)
Additional information 6 (3.73) 1 (1.64) 2 (4.35)
Patient version/leaﬂets/information 17 (10.56) 5 (8.20) 6 (13.04)
App/other digital formats 7 (4.35) 1 (1.64) 3 (6.52)
Translation/language 8 (4.97) 10 (16.39) 5 (10.87)
More graphic/pictorial information 5 (3.11)
More supporting evidence 5 (3.11)
Q&A by expert(s) 2 (1.24)
Recommendations based on expert opinion 1 (2.17)
Updating 2 (4.35)
Clinic
Endorsement of guidelines by local authority 1 (0.62) 3 (4.92)
Funding 4 (2.48) 1 (2.17)
Equipment 2 (1.24)
Management and staff receptivity 3 (1.86)
Protocol implementation 2 (1.24)
Specialized staff 1 (1.64)
Multidisciplinary/team work 1 (1.64)
Staff
Time 3 (1.86) 3 (4.92) 1 (2.17)
Education/courses 15 (9.32) 6 (9.84)
Motivational support 1 (0.62) 2 (3.28)
Patient
Education/awareness 4 (2.48) 2 (3.28) 1 (2.17)
Attitude/cooperation 1 (1.64)
Support not needed 19 (11.80) 3 (4.92) 8 (17.39)
Non-Codable 31 (19.25) 12 (19.67) 10 (21.74)
See Supplementary Tables SIII/SVI/SIX for the full list of the participants’ answers and the respective category.
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Figure 3 Participants intentions to use different types of implementation support provided by ESHRE.
implementation of the RPC guideline (e.g. ‘ﬁnd it difficult to co relate
due to ethical differences’, ‘against local habits’, ‘patients are often
refractory to psychological support’, ‘not cooperative’) and, to a lesser
extent, the ENDO guideline (e.g. ‘incorrigible habits, sociocultural
restraints’, ‘sometimes patients do not accept no surgery’). It should
be noted that some participants reported not experiencing any barriers
to the implementation of the ENDO and POI guidelines, but not the
RPC.
Perceived beneﬁcial support for
implementation of guidelines
Table IV presents the perceived beneﬁcial support to implement the
guidelines reported by 74 participants (total of 268 statements coded,
reported in Supplementary Tables SIII [ENDO], SVI [RPC] and SIX
[POI]). The most cited support was related to the guidelines them-
selves. Participants wanted clearer and more concise information on
the guidelines (e.g. ENDO, ‘more clear overview, different layout that
makes it more attractive and less confusing’, ‘short version’; RPC,
‘short crisp recommendation for quick reference’, ‘more concise writ-
ten summary’; POI, ‘small ﬂowchart to laminate in clinic’, ‘a quick sum-
mary’), better dissemination via multiple media (e.g. ENDO, ‘spread
of guidelines to all health providers’, ‘summarized guidelines sent per
email annually to all interested as a reminder’; RPC, ‘social media,
Facebook, emails; POI, ‘guidelines must be spread through social
media’) and translation to other languages (e.g. ENDO, ‘having the
guidelines in different languages’; RPC, ‘multiple language translation
with content validation’; POI, ‘a translated version’), as well as more
patient-orientated materials (e.g. ENDO, ‘interactive online shared
decision-making tool’, ‘simpliﬁed educational materials’; RPC, ‘leaﬂets
for patients’, ‘an illustrated guide for patient’; POI, ‘podcast or small
video guidance for patients’, ‘app’). Participants also reported wanting
more education and courses on ENDO (e.g. to have a chance to attend
ESHRE campuses’, ‘advocacy through seminar or workshop’) and RPC
guidelines (e.g. ‘group teaching of all staff’, ‘e-learning course’). Figure 3
shows that most participants (60% or over) would use e-learning
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courses, apps, printed pocket guidelines and a step-by-step guide for
implementation, if provided by ESHRE.
Discussion
Results from this survey-based study show that ESHRE’s evidence-
based guidelines are known and are being used worldwide. Guideline
implementation is perceived to result in the improvement of treat-
ment, better screening/evaluation/diagnosis and better psychosocial
and patient-centred care (among other positive changes), leading to
perceived beneﬁts for patients. However, on average only 30% of
those who know of the guidelines report implementing changes in
their routine practice, and <20% think that patients beneﬁt from it.
Although the guidelines are perceived as highly implementable, the
lack of translation, their non-friendly format (too long and compli-
cated) and lack of supporting evidence are reported barriers to their
implementation. Consistently, ESHRE members show willingness to
use support for implementation, namely by doing online courses and
using translated and engaging materials that provide a step-by-step
approach to implementation.
More than 700 ESHRE members from all over the world (85 coun-
tries, 6 continents) accessed the online survey. The results indicate that
the majority of ESHREmembers know about and access the guidelines.
Indeed, >80% of the respondents know the ENDO guideline, the ﬁrst
ESHRE guideline published in 2013, and almost 60% know the RPC,
POI and RPL guidelines, the former two published in 2015 and the
latter in 2018. Of those members who know the guidelines, around
half downloaded at least one version of it (guideline document,Human
Reproduction publication, pocket guideline, etc.). Results also indicate
that the guidelines are being used equally inside and outside Europe,
suggesting they have a wide geographical reach.
Overall, ESHRE members consider that the guidelines are of very
high quality and fairly implementable; in other words, they perceive
that it is possible to implement the guidelines at their clinics. Those who
stated they used a guideline, report a wide array of perceived positive
changes, mainly associated with the provision of better treatment,
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screening/evaluation/diagnosis and psychosocial and patient-centred
care. The changes reported are expected and speciﬁc considering
the recommendations of each guideline. For instance, participants
considered that the ENDO guideline helped them to make better
decisions about medical and surgical treatment of pain, that the RPC
guideline increased awareness about and led to the provision of better
psychosocial care, as well as more patient-centred care, and that the
POI guideline facilitated the identiﬁcation and treatment of patients
with POI. Finally, on average, every three out of four people whomade
changes perceived that their patients beneﬁted from it (ENDO 62%,
RPC 80%, POI 75%). Overall these results suggest that, when used,
the ESHRE guidelines have the potential to guide effective change at
clinics.
Despite the potential to improve the quality of health care delivery,
the current reality is that on average only one-fourth of those who
are aware of the guidelines go on to make changes in their routine
practice, and less than one-ﬁfth perceive that their patients beneﬁt from
the guidelines. One possible explanation for these low implementation
numbers may be that the guidelines are out of the professional remit of
many participants. Indeed, the RPC guideline is the only one that targets
all fertility staff members regardless of their professional background,
while the other three guidelines are mainly written for clinicians. The
results from the logistic regressions support this idea by showing that
clinicians are more likely than other fertility staff members to use
the guidelines in their daily practice. Supplementary Table SX reports
the data on dissemination, implementation and impact for clinicians
only. Percentages of use in daily practice are ∼30% higher for ENDO,
16% for RPC and 34% for POI, showing that clinicians are indeed
more likely to use the guidelines. Another possible reason for the
reported low implementation rates is that respondents might already
be following the guidelines and therefore did not need to make any
additional changes. We explored this possibility by analysing data from
an open-ended question (data not shown) where participants were
given the opportunity to justify the answer given to the question if they
or the clinic had made changes in their routine practice. These data
showed that on average 1–3 out of each 10 participants were already
following the guidelines (ENDO, 28.0%; RPC, 19.0%; POI, 19.2%; RPL,
11.4%). Overall these data show that one should not expect 100%
implementation rates because not all respondents are in a position
where they should be applying the guidelines and some are already
applying them. If we look at implementation considering the groups
targeted by each guideline (physicians for ENDO, POI and RPL; and all
fertility staff for RPC) then rates of use in daily practice vary between
29.5% (RPC) and 72.1% (ENDO) and rates of participants who made
changes vary between 18.9% (RPC) and 55.4% (ENDO), providing a
more optimistic view of implementation for all guidelines but the RPC.
Nevertheless, the data also indicate that the guidelines are not being
implemented because of perceived barriers. First, results from logistic
regressions suggest that perceived lack of quality of the guidelines is a
barrier to their use in routine practice. Second, results from qualitative
analysis show that participants identiﬁed other barriers that were
common to the three guidelines investigated: the lack of translated
versions (beyond English) and the lack of brief, friendly and engaging
formats were reported most frequently. The long and difficult format
has been reported frequently in other domains (Cabana et al., 1999;
Cochrane et al., 2007; Haagen et al., 2005). This is understandable
considering that fertility staff feel highly work- and time-pressured
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(Boivin et al., 2017) that some members of staff (e.g. clinicians) need
to familiarize themselves with all the guidelines and that many have
limited English proﬁciency. Contrary to what was expected and has
been previously described (Cabana et al., 1999; Cochrane et al., 2007;
Haagen et al., 2005), local barriers (i.e. clinic, staff and patient related)
seemed to be less relevant to implementation. The most signiﬁcant
ones were lack of ﬁnancial resources (clinics and patients), time and
knowledge/expertise. In the speciﬁc case of the RPC guideline, cultural
and normative factors also seemed to be relevant, which may reﬂect
the prevalence of a more medically orientated approach to fertility
treatment, as opposed to a more holistic patient-centred one, whereby
patient well-being and quality of life is highly valued by staff and patients
alike as an important treatment quality indicator (Picker Institute, 2012,
World Health Organization, 2007). It may be that respondents focused
more on barriers that they thought ESHRE could tackle, that is, those
directly related with the guidelines. It may also be that the lower
reporting of local barriers is associated with the smaller percentage of
people that are actually using the guidelines and therefore come across
these barriers.
Overall these results suggest that ESHRE’s current policy of investing
in the guidelines’ methodological quality and dissemination is impor-
tant, but insufficient to ensure their full implementation at clinics. On
the bright side, results suggest that it is feasible for ESHRE to address
some of the barriers to implementation, as most reported barriers
were related to the guidelines rather than the clinic, staff or patient.
Results on requested support for implementation further reinforce
this idea, as these focus on accessing brief and engaging materials (for
staff and patients), translated versions of the materials and (online)
training courses that provide clear instructions for implementation.
To a certain extent, ESHRE is already addressing these requests (e.g.
presentations on the guidelines at campus courses, pocket versions
of some documents), but the emphasis has been on communicating
what is recommended for staff to do. In the future ESHRE should put
the emphasis on how to do it at clinics and should try to ensure a
positive balance between learning time required and implementation
skills acquired for all guidelines-related educational activities.
ESHRE has invested heavily in developing evidence-based guidelines
to improve health care delivery across Europe. It is timely and nec-
essary to adopt the same evidence-based approach to understand
how well the guidelines are being disseminated and implemented as
well as their impact on patients. The current online survey allowed us
to develop a comprehensive picture of how the ESHRE community
views and uses the guidelines, with detailed information on which
changes were perceived to have been implemented plus any barriers
and desired support for implementation. However, some limitations
need to be acknowledged. The survey was limited to ESHRE members
and therefore not representative of the European population of fertility
health care professionals, which may be less sensitive to the beneﬁts of
evidence-based practice, less up-to-date on recent developments in
the ﬁeld and have lower English proﬁciency than respondents in this
survey. The survey was very long and required participants to provide
the same information for each of the four guidelines in a consecutive
way (ENDO, RPC, POI, RPL). This resulted in an increasing number
of missing data as we progressed through the guidelines answers. It is
unclear if missing data result from response fatigue or lack of interest
in the guidelines. Finally, the survey assessed participants’ perceptions
and not their actual practice at their clinics. The implication of these
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limitations is that the results reported may be too optimistic and may
only capture the views of those who actively engaged in trying to
implement the guidelines.
In sum, implementation tools for guidelines are important, although
there is very little evidence for their efficacy (Flodgren et al., 2016). The
survey’s results provide some clear input on the preferences of users
regarding implementation tools for the ESHRE guideline and suggest
that ESHRE should, ﬁrst, consider investing in the translation of the
guidelines and all associated materials into different languages. Second,
ESHRE should continue to develop new engaging ways of disseminating
the guidelines to different stakeholders (staff and patients). Using
different media formats seems to be valued by participants but it poses
additional challenges in terms of costs in production and translation.
Finally, ESHRE should consider investing in online education and training
focused on a ‘hands-on’ step-by-step approach to implementation. The
combination of these three strategies should constitute an important
step forward in addressing barriers to implementation. The barriers
and support requests were common to the three guidelines; therefore
support activities that proved to be efficient with one guideline could
be easily transferred to the remaining guidelines. Overall, these efforts
should bring ESHRE closer to improving the quality of fertility health
care across Europe.
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Supplementary data are available at Human Reproduction Open online.
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